SCHEMBL24310428

SCHEMBL24310428

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 4/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ ITK Q08881 1/20 0.37
▸ HRH4 Q9H3N8 3/20 0.36
▸ CTSC P53634 2/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34
▸ TTK P33981 1/20 0.34
▸ MAP3K7 O43318 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAP2K1 Q02750 1/20 0.33
▸ CCNK O75909 1/20 0.33
▸ CCNA2 P20248 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ CCND3 P30281 1/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ CDK6 Q00534 1/20 0.33
▸ TNK2 Q07912 1/20 0.33
▸ JAK2 O60674 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309719 0.90 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24310424 0.90 PDE2A (0.41) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24310171 0.90 CTSC (0.36) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24310158 0.89 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24309882 0.89 MAP4K1 (0.37) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24309386 0.88 JAK2 (0.37) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24309392 0.87 BRD4 (0.37) MAP4K1PDE2APDE10AITKHRH4
SCHEMBL24309929 0.87 MAP4K1 (0.33) MAP4K1IGF1RCCNA2CCND3CDK6
SCHEMBL24309917 0.84 MAPK14 (0.33) IGF1RJAK2JAK1
SCHEMBL24309744 0.84 LTA4H (0.38) IGF1RCCNKCCNA2CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback